{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:07:17Z","timestamp":1747181237542,"version":"3.40.5"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"50","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,15]]},"abstract":"<jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>The ring finger protein 213 (<jats:italic toggle=\"yes\">RNF213<\/jats:italic>) p.R4810K variant has been identified as being associated with Moyamoya disease (MMD), a condition that is more prevalent in East Asians. This association extends beyond cerebral vessels and has been implicated in coronary artery disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 36-year-old female was admitted to the emergency room with chest pain. Although the patient had no known underlying conditions or risk factors for atherosclerosis, she was diagnosed with unstable angina and underwent percutaneous coronary intervention. Given her older sister\u2019s ongoing treatment for MMD, it was suspected that the patient\u2019s coronary artery disease might be linked to the MMD-associated gene mutation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Coronary angiography revealed 80% narrowing of the proximal left anterior descending artery. Based on clinical symptoms and coronary angiography, we diagnosed it as unstable angina.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Intervention:<\/jats:title>\n            <jats:p>Due to the family history of MMD and detection of the <jats:italic toggle=\"yes\">RNF213<\/jats:italic> p.R4810K heterozygous variant in the patient\u2019s older sister, genetic counseling was recommended. Next-generation sequencing for vascular diseases was performed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>Genetic testing confirmed the presence of an <jats:italic toggle=\"yes\">RNF213<\/jats:italic> p.R4810K heterozygous variant in the patient, mirroring that in her sister. An <jats:italic toggle=\"yes\">RNF213<\/jats:italic> p.C4397R heterozygous variant was identified concomitantly, although it was categorized as a variant of uncertain significance. Coronary artery disease has been attributed to the <jats:italic toggle=\"yes\">RNF213<\/jats:italic> p.R4810K variant.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>Although MMD is rare in Western populations, it is more common in East Asian populations. Traditionally, MMD diagnoses have focused solely on the cerebral vessels without guidelines for the assessment of other vascular involvements. This familial case underscores the fact that a single genetic mutation can manifest in diverse ways in different diseases. Hence, the need and regularity of systemic vessel screening should be thoughtfully considered in such a context.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000036627","type":"journal-article","created":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T21:17:37Z","timestamp":1702675057000},"page":"e36627","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["RNF213 vasculopathy manifested in various forms within a family: A case report"],"prefix":"10.1097","volume":"102","author":[{"given":"Seong-Soo","family":"Lim","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sangshin","family":"Park","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Byeong Ho","family":"Oh","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Chungbuk National University Hospital, Cheongju, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiwook","family":"Jung","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Chungbuk National University Hospital, Cheongju, South Korea."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jang-Whan","family":"Bae","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, South Korea"},{"name":"Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4464-8613","authenticated-orcid":false,"given":"Dae-Hwan","family":"Bae","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, Chungbuk National University Hospital, Cheongju, South Korea"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"408","DOI":"10.3340\/jkns.2015.57.6.408","article-title":"Moyamoya syndrome: a window of Moyamoya disease.","volume":"57","author":"Phi","year":"2015","journal-title":"J Korean Neurosurg Soc"},{"key":"R2-20250504","doi-asserted-by":"crossref","first-page":"e22542","DOI":"10.1371\/journal.pone.0022542","article-title":"Identification of RNF213 as a susceptibility gene for Moyamoya disease and its possible role in vascular development.","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1161\/STROKEAHA.114.006244","article-title":"RNF213 rare variants in an ethnically diverse population with Moyamoya disease.","volume":"45","author":"Cecchi","year":"2014","journal-title":"Stroke"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s12881-015-0252-4","article-title":"Frequency of the Moyamoya-related RNF213 pArg4810Lys variant in 1,516 Korean individuals.","volume":"16","author":"Jang","year":"2015","journal-title":"BMC Med Genet"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.chest.2017.09.023","article-title":"Nonsyndromic peripheral pulmonary artery stenosis is associated with homozygosity of RNF213 pArg4810Lys regardless of co-occurrence of Moyamoya disease.","volume":"153","author":"Chang","year":"2018","journal-title":"Chest"},{"key":"R6-20250504","first-page":"1977","article-title":"Epidemiology, diagnosis and treatment of Moyamoya disease (Review).","volume":"17","author":"Zhang","year":"2019","journal-title":"Exp Ther Med"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"740","DOI":"10.4070\/kcj.1996.26.3.740","article-title":"A case of left coronary osteal stenosis combined with Moyamoya disease.","volume":"26","author":"Park","year":"1996","journal-title":"Korean Circ J"},{"key":"R8-20250504","doi-asserted-by":"crossref","first-page":"275","DOI":"10.4070\/kcj.2002.32.3.275","article-title":"A case of Moyamoya disease with total occlusion of left main coronary artery.","volume":"32","author":"Kim","year":"2002","journal-title":"Korean Circ J"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1161\/CIRCULATIONAHA.112.136473","article-title":"Coronary artery stenosis in moyamoya disease: tissue characterization by 256-slice multi-detector CT and virtual histology.","volume":"127","author":"Lee","year":"2013","journal-title":"Circulation"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3346\/jkms.2015.30.4.470","article-title":"Coronary heart disease in Moyamoya disease: are they concomitant or coincidence?","volume":"30","author":"Nam","year":"2015","journal-title":"J Korean Med Sci"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/jhg.2010.132","article-title":"A genome-wide association study identifies RNF213 as the first Moyamoya disease gene.","volume":"56","author":"Kamada","year":"2011","journal-title":"J Hum Genet"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"e56185","DOI":"10.7554\/eLife.56185","article-title":"Moyamoya disease factor RNF213 is a giant E3 ligase with a dynein-like core and a distinct ubiquitin-transfer mechanism.","volume":"9","author":"Ahel","year":"2020","journal-title":"Elife"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/ncb3376","article-title":"PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxia.","volume":"18","author":"Banh","year":"2016","journal-title":"Nat Cell Biol"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.molcel.2019.01.036","article-title":"Probing the global cellular responses to lipotoxicity caused by saturated fatty acids.","volume":"74","author":"Piccolis","year":"2019","journal-title":"Mol Cell"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1212\/WNL.0b013e318249f71f","article-title":"Homozygous c14576G>A variant of RNF213 predicts early-onset and severe form of Moyamoya disease.","volume":"78","author":"Miyatake","year":"2012","journal-title":"Neurology"},{"key":"R16-20250504","doi-asserted-by":"crossref","first-page":"155","DOI":"10.23838\/pfm.2022.00009","article-title":"Systemic vasculopathy associated with an RNF213 p.Arg4810Lys variant in moyamoya disease: a review.","volume":"6","author":"Kim","year":"2022","journal-title":"Precision Future Med"},{"key":"R17-20250504","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1159\/000525229","article-title":"Moyamoya syndrome in a patient with Williams syndrome: a case report.","volume":"57","author":"Akimoto","year":"2022","journal-title":"Pediatr Neurosurg"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"214","DOI":"10.4070\/kcj.2018.0380","article-title":"Chronic thromboembolic pulmonary hypertension: endovascular treatment.","volume":"49","author":"Ahn","year":"2019","journal-title":"Korean Circ J"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"170","DOI":"10.4070\/kcj.2022.0252","article-title":"Clinical course of suspected diagnosis of pulmonary tumor thrombotic microangiopathy: a 10-year experience of rapid progressive right ventricular failure syndrome in advanced cancer patients.","volume":"53","author":"Bak","year":"2023","journal-title":"Korean Circ J"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"843927","DOI":"10.3389\/fneur.2022.843927","article-title":"Ring finger protein 213 in Moyamoya disease with pulmonary arterial hypertension: a mini-review.","volume":"13","author":"Luo","year":"2022","journal-title":"Front Neurol"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS).","volume":"41","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC.","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC Guidelines for the management of cardiomyopathies: developed by the task force on the management of cardiomyopathies of the European Society of Cardiology (ESC).","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036627","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:14:18Z","timestamp":1746321258000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000036627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":23,"journal-issue":{"issue":"50","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000036627","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2023,12,15]]}}}